Skip to main content

Table 3 Comparison of blood indexes in PD patients with different disease durations

From: Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson’s disease

 

< 6 years

6 ~ 10 years

> 10 years

χ2/F

P

N (%)

55 (56.1)

29 (29.6)

14 (14.3)

/

/

WBCs (×109/L)

5.76 (5.08 ~ 6.61)b

5.53 (4.77 ~ 6.31)c

4.55 (4.09 ~ 5.6)

11.237

0.004

Neutrophils (× 109/L)

3.61 (3.1 ~ 4.51)b

3.52 (2.92 ~ 4.45)

2.79 (2.61 ~ 3.42)

7.963

0.019

Lymphocytes (×109/L)

1.54 ± 0.47

1.51 ± 0.62

1.24 ± 0.27

2.129

0.125

Monocytes (×109/L)

0.38 ± 0.1a

0.44 ± 0.13c

0.35 ± 0.07

4.072

0.02

Hb (×109/L)

159 (150 ~ 166)

160 (154.5 ~ 165)

150.5 (141.5 ~ 165)

4.503

0.105

UA (μmol/L)

303 (224 ~ 359)

294 (266 ~ 334)

289 (268 ~ 349.5)

0.034

0.983

TC (mmol/L)

4.42 ± 0.8

3.96 ± 0.89

4.25 ± 0.72

3.041

0.052

TG (mmol/L)

1.25 (0.94 ~ 1.83)

1.02 (0.8 ~ 1.61)

1.03 (0.53 ~ 1.18)

5.557

0.062

HDL-C (mmol/L)

1.17 ± 0.29

1.13 ± 0.28

1.3 ± 0.3

1.699

0.188

LDL-C (mmol/L)

2.53 ± 0.73

2.31 ± 0.68

2.43 ± 0.5

0.99

0.375

MHR (×109/mmol)

0.33 (0.25 ~ 0.41)

0.41 (0.26 ~ 0.51)c

0.27 (0.25 ~ 0.32)

7.477

0.024

NHR (×109/mmol)

3.3 (2.45 ~ 4.14)b

3.26 (2.41 ~ 4.61)c

2.07 (1.96 ~ 2.96)

9.975

0.007

NLR (×109/mmol)

2.56 (2.01 ~ 3.41)

2.58 (1.97 ~ 3.39)

2.69 (2.11 ~ 2.87)

0.085

0.958

  1. a< 6 years vs. 6 ~ 10 years, P < 0.05; b: < 6 years vs. > 10 years, P < 0.05; c: 6 ~ 10 years vs. > 10 years, P < 0.05